机译:ESMO-ESGO协商会议关于卵巢癌的会议建议:病理和分子生物学,早期和晚期阶段,边缘肿瘤和复发性疾病
Kliniken Essen Mitte Essen Germany;
Royal Marsden NHS Fdn Trust London England;
Gustave Roussy Canc Campus Villejuif France;
M Sklodowska Curie Inst Ctr Oncol Krakow Poland;
Hillel Yaffe Med Ctr Gynecol Oncol Unit Hadera Israel;
Charles Univ Prague Fac Med 1 Prague Czech Republic;
European Inst Oncol IRCCS Milan Italy;
Med Univ Innsbruck Innsbruck Austria;
Norwegian Radium Hosp Oslo Univ Hosp Dept Pathol Oslo Norway;
Maidstone &
Tunbridge Wells NHS Trust Tunbridge Wells Kent England;
Hosp Civils Lyon Lyon France;
Kliniken Essen Mitte Essen Germany;
Mauriziano Hosp Turin Italy;
Beatson West Scotland Canc Ctr Glasgow Lanark Scotland;
Univ Navarra Clin Madrid Spain;
Univ Hosp Basel Gynecol Canc Ctr Basel Switzerland;
Ctr Francois Baclesse Caen France;
Seoul Natl Univ Coll Med Seoul South Korea;
CHU Sart Tilman Notre Dame Bruyeres Chenee Belgium;
UCL Canc Inst London England;
Fdn Policlin Univ A Gemelli IRCCS Rome Italy;
Ludwig Maximilians Univ Hosp Univ Hosp Dept Obstet &
Gynaecol Munich Germany;
Belfast Hlth &
Social Care Trust Belfast Antrim North Ireland;
Imperial Coll London England;
Tokai Univ Sch Med Hiratsuka Kanagawa Japan;
Copenhagen Univ Hosp Rigshosp Copenhagen Denmark;
Gustave Roussy Canc Campus Villejuif France;
Canc Ctr Oxford England;
Leuven Canc Inst Leuven Belgium;
St James Hosp Dublin Ireland;
Gustave Roussy Canc Campus Villejuif France;
Inst Bergonie Bordeaux France;
Ist Nazl Tumori IRCCS Fdn G Pascale Naples Italy;
Inst Bergonie Bordeaux France;
Ctr Leon Berard Lyon France;
Alexandra Reg Gen Hosp Athens Greece;
Charite Univ Med Berlin Berlin Germany;
Koc Univ Hosp Istanbul Turkey;
Osped San Giovanni Bellinzona Oncol Inst Southern Switzerland Bellinzona Switzerland;
Barts Hlth NHS Trust London England;
Natl Univ Canc Inst Singapore Singapore Singapore;
Univ Hosp KU Leuven Leuven Belgium;
Azienda Socio Sanit Terr Spedali Civili Brescia Brescia Italy;
Acad Med Ctr Amsterdam Amsterdam Netherlands;
Leuven Canc Inst Leuven Belgium;
Univ Med Ctr Utrecht Utrecht Netherlands;
Innsbruck Med Univ Univ Hosp Innsbruck Austria;
ovarian cancer; adjuvant treatment; surgery; pathology; molecular biology; recurrent disease;
机译:ESMO-ESGO协商会议关于卵巢癌的会议建议:病理和分子生物学,早期和晚期阶段,边缘肿瘤和复发性疾病
机译:根据国际肿瘤崭露头角的宣传协商会议(ITBCC)建议强烈预测II期结直肠癌的无病生存率
机译:根据国际肿瘤崭露头角的宣传协商会议(ITBCC)建议强烈预测II期结直肠癌的无病生存率
机译:晚期卵巢癌肿瘤基质微环境的生物工程3维模型
机译:整合基因组学和分子生物学:鉴定前列腺癌致癌基因SOX4的转录靶标并评估Aurora激酶抑制作用对化疗耐药的卵巢癌的疗效
机译:使用ADNEX模型评估术前卵巢癌的风险以区分良性临界早期和晚期浸润性和继发转移性肿瘤:前瞻性多中心诊断研究
机译:使用ADNEX模型评估术前卵巢癌的风险,以区分良性,临界,早期和晚期浸润性和继发性转移性肿瘤:前瞻性多中心诊断研究